Advancements in AI and robotics drive innovation in oncology in India

The global oncology sector has seen a funding of $424 million this year, with India showcasing innovation and funding trends in new technologies. With 94 companies established in India, Perfint Healthcare leads in funding followed by Immuneel and Zumutor.

Oncology drugs dominate with $27.1 million in funding, led by key players like ImmunoACT and Immuneel. Bengaluru stands out with 20 founded companies in the sector, reflecting the city’s prominence in the industry. The sector is spearheading advancements in AI, robotics, and genomic sequencing for cancer treatment methodologies.

In 2023, the oncology sector received a total funding of $9.2 billion, with 12 unicorn companies emerging. Top investors like Orbimed, EIC Fund, and RA Capital Management play a pivotal role. Y Combinator, Alexandria, and Proxima Ventures are top seed investors, while Orbimed, Alexandria, and RA Capital Management lead in early-stage investments, as per the report by market intelligence firm Tracxn.